de Havenon Adam, Yuan Chun, Tirschwell David, Hatsukami Thomas, Anzai Yoshimi, Becker Kyra, Sultan-Qurraie Ali, Mossa-Basha Mahmud
Department of Neurology, University of Utah, 175 North Medical Drive, Salt Lake City, UT 84132, USA.
Department of Radiology, University of Washington, 325 9th Avenue, Seattle, WA 98104, USA.
Case Rep Radiol. 2015;2015:356582. doi: 10.1155/2015/356582. Epub 2015 Aug 6.
Intracranial atherosclerotic disease (ICAD) accounts for 9-15% of ischemic stroke in the United States. Although highly stenotic ICAD accounts for most of the strokes, it is assumed that nonstenotic ICAD (nICAD) can result in stroke, despite being missed on standard luminal imaging modalities. We describe a patient with nICAD who suffered recurrent thromboembolic stroke and TIA but had a negative conventional stroke workup. As a result, they were referred for high-resolution magnetic resonance imaging (HR-MRI) of the arterial vessel wall, which identified a nonstenotic plaque with multiple high-risk features, identifying it as the etiology of the patient's thromboembolic events. The diagnosis resulted in a transition from anticoagulation to antiplatelet therapy, after which the patient's clinical events resolved. HR-MRI is an imaging technique that has the potential to guide medical management for patients with ischemic stroke, particularly in cryptogenic stroke.
在美国,颅内动脉粥样硬化性疾病(ICAD)占缺血性卒中的9%至15%。尽管高度狭窄的ICAD导致了大多数卒中,但据推测,非狭窄性ICAD(nICAD)也可导致卒中,尽管在标准管腔成像模式下会被漏诊。我们描述了一名患有nICAD的患者,该患者反复发生血栓栓塞性卒中和短暂性脑缺血发作(TIA),但常规卒中检查结果为阴性。因此,他们被转诊进行动脉血管壁的高分辨率磁共振成像(HR-MRI),该检查发现了一个具有多个高危特征的非狭窄斑块,确定其为患者血栓栓塞事件的病因。这一诊断结果导致治疗从抗凝治疗转变为抗血小板治疗,此后患者的临床事件得到缓解。HR-MRI是一种成像技术,有潜力指导缺血性卒中患者的医疗管理,尤其是在隐源性卒中患者中。